Influence of age and renal function on the concentration of rivaroxaban in plasma and urine in patients undergoing primary elective total knee and hip replacement surgery

被引：0
|
作者：
Schulze, Astrid [1 ]
Marx, Svetlana [2 ]
Weiss, Christel [3 ]
Harenberg, Job [2 ]
机构：
[1] Fac Med Mannheim, Dept Orthoped Surg, D-68167 Mannheim, Germany
[2] Fac Med Mannheim, Dept Clin Pharmacol, D-68169 Mannheim, Germany
[3] Fac Med Mannheim, Inst Biometrie & Stat, D-68167 Mannheim, Germany
来源：
THROMBOSIS RESEARCH | 2012年 / 130卷
关键词：
D O I：
10.1016/j.thromres.2012.08.038
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [1] Determination of rivaroxaban in plasma, serum, and urine from patients undergoing total hip and knee replacement surgery
    Harenberg, J.
    Schulze, A.
    Marx, S.
    Kraemer, R.
    Weiss, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 51 - 52
  • [2] Economic comparison of rivaroxaban with enoxaparin in canadian patients undergoing total hip and total knee replacement
    Wells, P.
    Diamantopoulos, A.
    McDonald, H.
    Forster, F.
    Lees, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 477 - 477
  • [3] Rivaroxaban: A direct factor Xa inhibitor for VTE prophylaxis in patients undergoing total knee or hip replacement surgery
    Nunokawa, Nikki
    Wong, Heather
    Song, Jessica C.
    FORMULARY, 2009, 44 (08) : 226 - +
  • [4] Indirect comparison of the efficacy and safety of dabigatran, rivaroxaban and apixaban in elective total knee and hip replacement surgery
    Marx, Svetlana
    Weiss, Christel
    Wehling, Martin
    Scharf, Hanns-Peter
    Dahl, Ola
    THROMBOSIS RESEARCH, 2012, 130 : S101 - S101
  • [5] Changes of thrombelastography in patients undergoing elective primary total knee and total hip replacement with low molecular heparin prophylaxis
    Yang, Yi
    Yao, Zhenjun
    Dai, Wenda
    Shi, Peng
    Luo, Lei
    Zhang, Chi
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2014, 9
  • [6] Changes of thrombelastography in patients undergoing elective primary total knee and total hip replacement with low molecular heparin prophylaxis
    Yi Yang
    Zhenjun Yao
    Wenda Dai
    Peng Shi
    Lei luo
    Chi Zhang
    Journal of Orthopaedic Surgery and Research, 9
  • [7] An open-label study of dabigatran pharmacokinetics and pharmacodynamics in patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery
    Eriksson, B.
    Mikuska, Z.
    Feuring, M.
    Amiral, J.
    Haertter, S.
    Stangier, J.
    Nehmiz, G.
    Lobmeyer, M.
    Weitz, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 643 - 644
  • [8] Prothrombin Time and Bleeding Events in Patients Undergoing Total Hip or Knee Replacement Surgery Receiving 10 Mg Rivaroxaban
    Haas, Sylvia
    Turpie, Alexander G. G.
    Lassen, Michael Rud
    Kakkar, Ajay K.
    Eriksson, Bengt
    Vogtlaender, Kai
    Kubitza, Dagmar
    Mueck, Wolfgang
    Gent, Michael
    Misselwitz, Frank
    Berkowitz, Scott D.
    BLOOD, 2009, 114 (22) : 828 - 828
  • [9] Personality, function and satisfaction in patients undergoing total hip or knee replacement
    Ramaesh, Rishikesan
    Jenkins, Paul
    Lane, Judith V.
    Knight, Sara
    Macdonald, Deborah
    Howie, Colin
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2014, 19 (02) : 275 - 281
  • [10] Renal function after elective total hip replacement
    Perregaard, Helene
    ACTA ORTHOPAEDICA, 2016, 87 (04) : 434 - 435
12345